All Is Not Quiet on the Western Front

A grab bag of advances is making Western blots faster, more sensitive, and more reliable.

Written byKelly Rae Chi
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

COURTESY OF ADVANSTA INC.If you don’t look too closely, Western blots are seemingly the same slog as when they were first described in 1979. You separate proteins by size (or charge) using gel electrophoresis, transfer them to a membrane, and probe the membrane using antibodies to your particular protein. Westerns have been a staple in protein research for many years, allowing researchers to identify, and sometimes semiquantify, proteins within tissues and cell cultures. It’s easy to take them for granted. At the same time, the familiar blots are often the subject of scrutiny, fodder for fraud, and the reason behind some research retractions.

Western blotting is moving in the right direction, though. In recent years, new reagents and instruments have made Westerns more sensitive and have condensed some of the main steps, namely electrophoresis, blotting, and visualization. Although many researchers still use chemiluminescence detection and X-ray film, the introduction of digital fluorescence imaging has boosted the technique’s sensitivity and reliability and pushed it into the “quantitative” rather than semiquantitative realm. New advances are also making it possible to study proteins in single cells, or to probe limited or precious samples—and to automate some parts of the process. And users are taking greater care in addressing the issue of reliable controls.

The Scientist spoke with researchers and companies working to make Westerns a little easier and more reliable. Here’s ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies